London · Clinical practice and responsibilities
Consultant Clinical Oncologist: three years of clinical responsibility
During three years in London, Dr Alexandre Kaliski worked as a Consultant Clinical Oncologist, with responsibility for his patients and autonomy in clinical decisions. This senior specialist grade in the British hospital system is distinct from academic titles.
His work took place in the settings of Barts Cancer Centre, St Bartholomew’s Hospital, the Royal London Hospital and the Harley Street Clinic. He organised and chaired multidisciplinary meetings — tumour boards — with Professor Thomas Powles and Dr Nick Plowman, particularly in urological oncology. These meetings bring together the patient’s records and the views of the relevant specialties to discuss the care strategy.
Documented recognition in the United Kingdom
The General Medical Council documents his initial registration and recognition in Clinical oncology on the Specialist Register from 19 September 2008, in relation to that earlier period of practice in the United Kingdom (GMC no. 7010616). View the UK register entry ↗
The early years of CyberKnife in the United Kingdom
The Harley Street Clinic was home to the first British CyberKnife centre from February 2009. Working with Dr Nick Plowman, and subsequently in the Barts setting, this activity combined robotic radiosurgery, multidisciplinary discussions and preclinical research, particularly on prostate irradiation. Exchanges with the angiogenesis laboratory at Queen Mary University complemented this experience.
The Institute of Cancer Research’s list of UKGPCS study collaborators lists Dr Alexandre L. Kaliski at St Bartholomew’s Hospital, in the section that also includes Nicholas Plowman.
Training in both medicine and science
Dr Kaliski holds a medical doctorate (MD), the French DES in oncology and radiotherapy, and the French DESC in oncology. He undertook undergraduate clinical placements and postgraduate residency in the Hôpitaux de Paris, developing his training in medical oncology, radiotherapy and haematology.
He also holds a scientific doctorate (PhD) in radiobiology and cancer biology. He defended his PhD in 2007 at Université Paris-Sud, Paris XI, under the supervision of Professor Nathalie Lassau, before a committee chaired by Professor Thomas Tursz. Université Paris-Saclay succeeded Paris-Sud.
His medical thesis, on non-Hodgkin lymphomas, was defended before a committee chaired by Professor Christian Gisselbrecht. This training connects the study of cancer mechanisms with decisions about patient care.
| Qualification or milestone | What it means |
|---|---|
| MD and PhD | A medical doctorate and a scientific doctorate in radiobiology and cancer biology: two distinct doctorates. |
| DES in oncology and radiotherapy | French diploma of specialist studies in the discipline. |
| DESC in oncology | French diploma of complementary specialist studies in oncology. |
| AIHP | Former postgraduate resident in the Hôpitaux de Paris: a stage in hospital training. |
| Former CCU-AH at Gustave Roussy | University clinical lecturer and hospital assistant: a French role combining patient care, teaching and research. |
| Harvard/MGH, Columbia and London | Clinical training at Massachusetts General Hospital, research at Columbia University and clinical oncology practice in London. |
| Consultant Clinical Oncologist in London | Three years in a senior specialist role, with clinical autonomy and responsibility for multidisciplinary discussions. |
His training and clinical exchanges developed alongside physicians including Professors Éliane Gluckman, Christian Gisselbrecht, Marc Spielmann and Thierry Le Chevalier, during his career at AP-HP, Gustave Roussy, Institut Curie, Saint-Louis and Saint-Antoine. Publications and details of these career stages are accessible from this page.
Gustave Roussy, AP-HP and hospital responsibilities
As a former university clinical lecturer and hospital assistant at Gustave Roussy, he combined clinical practice, research and teaching for postgraduate residents, medical students on clinical placements and medical physics students. His career includes hospital physician posts at AP-HP.
As head of the oncology and radiotherapy department in Troyes from 2019 to 2024, he was responsible for clinical coordination and organising multidisciplinary meetings across several areas of oncology. This role built on the experience of multidisciplinary decision-making he had gained in London.
Bringing new technologies into clinical use
Over the course of his career, his responsibilities as head of department have also included bringing new stereotactic radiotherapy and radiosurgery equipment into clinical use, in conjunction with medical physics teams. His London experience with CyberKnife informed this coordination of care organisation, clinical indications and the teams’ technical work.
United States: clinical training and research
At Columbia University in New York, Dr Kaliski conducted experimental research in the molecular biology of cancer in Professor I. Bernard Weinstein’s laboratory, supported by a MICEFA scholarship, in 1991.
In 1998, he undertook clinical training in haematology at Massachusetts General Hospital, in the Harvard Medical School environment, with Professor Howard J. Weinstein. These American experiences combined laboratory research and specialist clinical training.
Publications across several areas of oncology
His work covers, among other subjects, interactions between irradiation, angiogenesis and the tumour microenvironment, as well as functional imaging. He is the first author of an article in Molecular Cancer Therapeutics on the inhibition of radiation-induced tumour invasion.
He has also co-authored publications in medical oncology, on paragangliomas and radiosurgery, and in haematology and allogeneic transplantation with Professor Éliane Gluckman’s team at Saint-Louis. The Research section provides references and access to available articles.
Endocrine Reviews: a publication with John R. Adler Jr.
In Endocrine Reviews (2014), Alexandre Kaliski is the second author of a review of head and neck paragangliomas, co-authored with, among others, John R. Adler Jr. (sixth author), a Stanford neurosurgeon and inventor of CyberKnife. The article examines functional imaging and radiosurgery among diagnostic and therapeutic approaches.
Current Approaches and Recent Developments in the Management of Head and Neck Paragangliomas. Endocrine Reviews. 2014;35(5):795–819. DOI: 10.1210/er.2014-1026.
Israel: international experience
His international career includes experience in oncology and radiotherapy at Sheba Medical Center and Ichilov. This experience complements the French, British and American stages of his training and practice.
ACLS (Advanced Cardiovascular Life Support) training, American Heart Association, 2016: additional training in the management of cardiovascular emergencies.
At the Oncologie Victor Hugo practice
The consultation draws on this experience to provide a personalised review of the patient’s records and explain the available options. Dr Kaliski sees patients at 1 Villa Victor Hugo, 75016 Paris, in French, English and German, in liaison with the teams involved in their care.
Publications and detailed career history
- Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion ↗
- Current Approaches and Recent Developments in the Management of Head and Neck Paragangliomas ↗
- Radiobiology & tumour microenvironment ↗
- Radiotherapy & complex tumours ↗
- GMC — historical recognition in Clinical oncology from September 2008 ↗
- Institute of Cancer Research — UKGPCS collaborators by hospital ↗
- BMA — the consultant role and hospital grade ↗
- Care Quality Commission — Harley Street and the first British CyberKnife centre ↗
- Stanford — the history of CyberKnife and John R. Adler Jr. ↗
Browse publications by field · Explore training and distinctions · Read the full biography
Your appointment in Paris 16
Oncologie Victor Hugo — Dr Alexandre Kaliski
1 Villa Victor Hugo, 75016 Paris · 07 44 58 57 63
Consultations in French, English and German.
The practice operates under the French sector 2 agreement. Fees shown on the website: €289 for an initial consultation, a follow-up or a video consultation. Arrangements are specified when booking; statutory provisions on third-party payment and regulated fees apply to eligible patients.
The possibility of a video consultation is considered according to the clinical situation and the country where the patient is located. For your medical documents, use the secure channels provided within your care pathway, including Doctolib where available.
Book on Doctolib ↗